Aktiesnakken — November 2009
-
ok, det kan så være, for det virker da mærkeligt
-
er det ikke lidt skidt?
-
Genmab has its own production facility where we expect
to manufacture zalutumumab for commercial us -
tyder da ikke på at gsk vil købe noget?
-
-
ser du det positivt solsen??
-
Solsen den side har da aldrig været der før har den det?
-
ah ok, der var jeg lige hurtig nok. Det er ikke den merrill der kører showet
-
skal vi holde hinanden selskab frem til regnskab eller har i små børn der skal kvæles?
-
det er blot datarum-udbyderen der pudsigt nok hedder merrill også.... jeg troede lige at det var Merrill Lynch
-
har 2.... er dette her positivt???? kan simpelthen ikke gennemskue den
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind